Anus Laboratories Ltd

Anu's Lab. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Anus Laboratories Ltd

₹ 0.24 0.00%
16 Mar 2015
anulabs.com
About

Anu's Laboratories Limited manufactures and supplies drug intermediates and related products for the pharmaceutical industry.

[ add key points ]
Website
  • Market Cap ₹ Cr.
  • Current Price ₹ 0.24
  • High / Low ₹ /
  • Stock P/E
  • Book Value ₹ 6.77
  • Dividend Yield 0.00 %
  • ROCE 11.7 %
  • ROE 2.28 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Stock is trading at 0.04 times its book value

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • Company has a low return on equity of 8.50% over last 3 years.
  • Dividend payout has been low at 3.80% of profits over last 3 years
  • Company's cost of borrowing seems high

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Operating Profit
OPM %
Interest
Depreciation
Profit before tax
Tax %
EPS in Rs
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012
83 104 146 155 198 262 256
72 81 111 120 161 216 217
Operating Profit 11 23 35 35 36 46 40
OPM % 13% 22% 24% 23% 18% 18% 15%
1 1 3 -0 2 -4 0
Interest 3 5 8 7 11 17 26
Depreciation 1 1 1 2 2 4 8
Profit before tax 8 18 28 26 26 21 6
Tax % 26% 26% 36% 37% 19% 37% 46%
6 14 18 16 21 13 3
EPS in Rs 0.67 0.14
Dividend Payout % 14% 6% 7% 12% 11% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 20%
3 Years: 18%
TTM: -2%
Compounded Profit Growth
10 Years: %
5 Years: -23%
3 Years: -40%
TTM: -76%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: 12%
3 Years: 9%
Last Year: 2%

Balance Sheet

Figures in Rs. Crores

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012
Equity Capital 5 8 8 12 24 24 24
Reserves 7 24 43 134 137 138 141
18 27 41 41 81 97 131
17 22 34 38 40 33 38
Total Liabilities 48 81 126 224 282 292 334
14 21 22 27 43 94 94
CWIP 0 4 4 17 38 22 35
Investments 2 3 3 3 3 0 0
32 53 97 178 198 176 205
Total Assets 48 81 126 224 282 292 334

Cash Flows

Figures in Rs. Crores

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012
-5 3 -7 -42 13 28 -10
-6 -13 -3 -19 -40 -23 -19
10 11 9 63 27 -4 26
Net Cash Flow -0 2 -1 2 1 2 -3
Free Cash Flow -9 -9 -10 -61 -26 6 -29
CFO/OP -43% 14% -19% -83% 60% 74% -18%

Ratios

Figures in Rs. Crores

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012
Debtor Days 22 26 57 146 124 77 119
Inventory Days 165 212 231 269 206 140 135
Days Payable 91 92 63 85 72 13 12
Cash Conversion Cycle 96 145 225 330 258 204 242
Working Capital Days 72 112 163 317 281 169 206
ROCE % 52% 48% 25% 17% 17% 12%

Shareholding Pattern

Numbers in percentages

Shareholding pattern is currently not available for this company.

Documents

Announcements

Annual reports

DRHP